COR vs HCA
COR: North America's largest pharmaceutical and healthcare product distributor, serving pharmacies, hospitals, and health systems with branded and generic drugs, medical supplies, and specialty healthcare services. HCA: One of the largest U.S. for-profit hospital operators, managing 190 hospitals and 121 ambulatory surgery centers across 19 states and England, generating $76+ billion in annual revenue.
Side-by-side fundamentals
| Metric | COR | HCA | Edge |
|---|---|---|---|
| Price as of 2026-07-09 close | $302.46 | $409.01 | |
| Market cap as of 2026-07-10 | $58.8B | $89.9B | |
| P/E as of 2026-07-10 | 23.09 | 13.23 | HCA lower |
| PEG as of 2026-07-10 | 2.03 | 1.31 | HCA lower |
| Net margin as of 2026-07-10 | +0.8% | +8.9% | HCA higher |
| Gross margin as of 2026-07-10 | +3.8% | +85.0% | HCA higher |
| Operating margin as of 2026-07-10 | +0.8% | +15.7% | HCA higher |
| ROE as of 2026-07-10 | +115.9% | +695.7% | HCA higher |
| ROA as of 2026-07-10 | +3.3% | +11.3% | HCA higher |
| Debt / equity as of 2026-07-10 | 3.65 | 125.80 | COR lower |
| Revenue growth (YoY) as of 2026-07-10 | +6.0% | +6.7% | HCA higher |
| Revenue CAGR (3y) SEC XBRL | +10.4% | +7.9% | COR higher |
| Dividend yield as of 2026-07-10 | +0.8% | +0.8% | COR higher |
| Dividend streak (yrs) SEC XBRL | 4 | 5 | HCA higher |
| Beta as of 2026-07-10 | 0.58 | 1.11 | |
| 1-year return as of 2026-07-09 close | +0.8% | +8.7% | HCA higher |
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date; "Edge" cells are a pure numeric comparison, not a recommendation.